My only concern is that why would a prospective lithium partner pay $300m for a 50% share of a lithium company when the FFX share price of 23c gives a market cap of $180m.
It would be cheaper for them to launch an aggressive takeover of FFX.
- Forums
- ASX - By Stock
- FFX
- Share allocation
Share allocation, page-20
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online